date,title,source
Oct-17-18,Regeneron's Dupixent Meets Goals in Nasal Polyps Studies,Zacks
Oct-17-18,Canadians are invited to join the conversation: Raise Your Hand for Diabetes,CNW Group
Oct-19-18,Sanofi drug Dupixent wins U.S. FDA approval to treat asthma,Reuters
Oct-19-18,Sanofi drug Dupixent wins U.S. FDA approval to treat asthma,Reuters
Oct-23-18,Breakthroughs in Breast Cancer Research,PR Newswire
Oct-24-18,"Amgen cuts price of cholesterol drug by almost 60%, echoing rival's move",CNBC
Oct-29-18,Will Sanofi (SNY) Beat Estimates Again in Its Next Earnings Report?,Zacks
Oct-29-18,Esperion stock surges 15% on late-stage results for cholesterol drug,MarketWatch
Oct-30-18,FDA grants priority review for Sanofi's dengue vaccine candidate,PR Newswire
Oct-30-18,A Closer Look At Sanofis (EPA:SAN) Uninspiring ROE,Simply Wall St.
Oct-31-18,Sanofi (SAN) Q3 Earnings Conference Call Transcript,Motley Fool
Oct-31-18,Sanofi (SNY) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-31-18,Sanofi's (SNY) Q3 Earnings and Sales Surpass Estimates,Zacks
Oct-31-18,European shares bounce as investors find comfort in earnings,Reuters Videos
Oct-31-18,Sanofi Q3 2018 Performance Confirms Return to Growth,PR Newswire
Oct-31-18,Vaccines and Genzyme help Sanofi keep promise of return to growth,Reuters
Oct-31-18,[$$] European Corporate Roundup,The Wall Street Journal
Oct-31-18,Vaccines and Genzyme help Sanofi keep promise of return to growth,Reuters
Oct-31-18,Sanofi: 3Q Earnings Snapshot,Associated Press
Oct-31-18,"Sanofi Lifts Forecast as Vaccines, Eczema Drug Provide Fuel",Bloomberg
Oct-31-18,[$$] Sanofi Returns to Growth,The Wall Street Journal
